However, to date, credible functional validation data exist only for MASP1. Thus, in agreement with our findings, a recent publication reported that the expression of MASP1 was downregulated in multiple human cancers, including the four SCTs investigated in the current study [88]. Here, MASP1 is linked to cancer.